Health Blueprint

Back to Longevity News

News summary

Circular Genomics takes blood-test approach to Alzheimer’s

Source: Longevity Technology • Published: 11 Nov 2026, 15:51

Summarized by Masters of Longevity from Longevity Technology.

Circular Genomics will profile blood circular RNA during an Alzheimer's drug study.

Circular Genomics takes blood-test approach to Alzheimer’s
Key Takeaways
  • Circular Genomics is profiling circRNAs during an LM11A-31 trial.
  • CircPath is being used to search for circRNA treatment biomarkers.
  • Blood circRNA signals may indicate responders but causality remains unproven.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.